Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Nakamura

Showing results (631-640 of 709) with videos related to

Pageof 71
Sort By:
Scientific Reports|December 1, 2022
The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinomaTakayuki Kondo, Kisako Fujiwara, Miyuki Nakagawa, et al.
Journal of Cardiology|March 23, 2020
Quality indicators of palliative care for acute cardiovascular diseasesAtsushi Mizuno, Mitsunori Miyashita, Takashi Kohno, et al.
Journal of Gastroenterology|April 7, 2024
Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinomaKisako Fujiwara, Takayuki Kondo, Kentaro Fujimoto, et al.
Vascular Medicine (London, England)|October 16, 2023
Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteriesHans van Overhagen, Masato Nakamura, Patrick J Geraghty, et al.
Cardiovascular Intervention and Therapeutics|June 28, 2014
Outcomes of the largest multi-center trial stratified by the presence of diabetes mellitus comparing sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in patients with coronary artery disease. The Japan drug-eluting stents evaluation: a randomized trial (J-DESsERT)Masato Nakamura, Toshiya Muramatsu, Hiroyoshi Yokoi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2022
Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE TrialTakayuki Yoshino, Eiji Oki, Toshihiro Misumi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 30, 2022
Twelve-month safety and effectiveness of TCD-17187 drug-coated balloon for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteryOsamu Iida, Yoshimitsu Soga, Shu-Ichi Seki, et al.
International Journal of Cardiology|January 31, 2016
Three-year follow-up outcomes of SES and PES in a randomized controlled study stratified by the presence of diabetes mellitus: J-DEsSERT trialMasato Nakamura, Toshiya Muramatsu, Hiroyoshi Yokoi, et al.
International Journal of Molecular Sciences|October 14, 2022
Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B VirusYaojia Ma, Shingo Nakamoto, Junjie Ao, et al.
CVIR Endovascular|April 24, 2026
Three-year outcomes of the TCD-17187 (Kanshas) drug-coated balloon for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteryShu-Ichi Seki, Yoshimitsu Soga, Osamu Iida, et al.
Pageof 71

Showing results (631-640 of 709) with videos related to

Sort By:
Pageof 71
Scientific Reports|December 1, 2022
The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinomaTakayuki Kondo, Kisako Fujiwara, Miyuki Nakagawa, et al.
Journal of Cardiology|March 23, 2020
Quality indicators of palliative care for acute cardiovascular diseasesAtsushi Mizuno, Mitsunori Miyashita, Takashi Kohno, et al.
Journal of Gastroenterology|April 7, 2024
Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinomaKisako Fujiwara, Takayuki Kondo, Kentaro Fujimoto, et al.
Vascular Medicine (London, England)|October 16, 2023
Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteriesHans van Overhagen, Masato Nakamura, Patrick J Geraghty, et al.
Cardiovascular Intervention and Therapeutics|June 28, 2014
Outcomes of the largest multi-center trial stratified by the presence of diabetes mellitus comparing sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in patients with coronary artery disease. The Japan drug-eluting stents evaluation: a randomized trial (J-DESsERT)Masato Nakamura, Toshiya Muramatsu, Hiroyoshi Yokoi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2022
Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE TrialTakayuki Yoshino, Eiji Oki, Toshihiro Misumi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 30, 2022
Twelve-month safety and effectiveness of TCD-17187 drug-coated balloon for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteryOsamu Iida, Yoshimitsu Soga, Shu-Ichi Seki, et al.
International Journal of Cardiology|January 31, 2016
Three-year follow-up outcomes of SES and PES in a randomized controlled study stratified by the presence of diabetes mellitus: J-DEsSERT trialMasato Nakamura, Toshiya Muramatsu, Hiroyoshi Yokoi, et al.
International Journal of Molecular Sciences|October 14, 2022
Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B VirusYaojia Ma, Shingo Nakamoto, Junjie Ao, et al.
CVIR Endovascular|April 24, 2026
Three-year outcomes of the TCD-17187 (Kanshas) drug-coated balloon for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteryShu-Ichi Seki, Yoshimitsu Soga, Osamu Iida, et al.
Pageof 71